Potential Risks and Mitigation Strategies Before the Conduct of a Clinical Trial: An Industry Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|11|1|47-55

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.11, Iss.1, 2016-03, pp. : 47-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Risks and Mitigation Strategies During the Conduct of a Clinical Trial: An Industry Perspective

By  

Reviews on Recent Clinical Trials, Vol. 13, Iss. 1, 2018-01 ,pp. : 52-60

Bentham Science Publishers

Access to resources Recommend Favorite

Opioid Therapy and Sleep Disorders: Risks and Mitigation Strategies

By  

PAIN MEDICINE, Vol. 16, Iss. S1, 2015-10 ,pp. : S22-S26

John Wiley & Sons Inc

Access to resources Recommend Favorite

To Conduct Clinical Trial in China, To Go or Not To Go

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 217-221

Bentham Science Publishers

Access to resources Recommend Favorite

Heterogeneity in recent‐onset type 1 diabetes – a clinical trial perspective

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 6, 2015-09 ,pp. : 588-594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parents report positive experiences about enrolling babies in a cord‐related clinical trial before birth

By  

ACTA PAEDIATRICA, Vol. 104, Iss. 4, 2015-04 ,pp. : e164-e170

John Wiley & Sons Inc

Access to resources Recommend Favorite